Free fatty acid receptors (FFARs) are G protein-coupled receptors (GPCRs) activated by free fatty acids (FFAs). The four well-characterized FFARs are FFAR1/GPR40, FFAR2/GPR43, FFAR3/GPR41, and FFAR4/GPR120. FFARs are categorized according to the chain length of FFA ligands that activate each FFAR; FFA2 and FFA3 are activated by short chain FFAs, mainly acetate, butyrate, and propionate. GPR84 is activated by medium-chain FFAs, whereas FFA1 and GPR120 are activated by medium- or long-chain FFAs. Thus, each FFAR can act as an FFA sensor with selectivity for a particular FFA carbon chain length derived from food or food derived metabolites. FFARs have been reported to have physiological functions such as facilitation of insulin and incretin hormone secretion, adipocyte differentiation, anti-inflammatory effects, neuronal responses, and taste preferences. These physiological functions of FFARs could be considered to regulate energy and immune homeostasis. Therefore, FFARs have been targeted in therapeutic strategies for the treatment of metabolic disorders including type 2 diabetes and metabolic syndrome.
(R)-AM-1638 是 AM-1638(MS-E80347)的 R-型异构体,而 AM-1638 是一种口服活性的全 GPR40 激动剂,其 EC50 为 0.16 μM。
(R)-CFMB 是 CFMB (MS-O68369) 的 R 型异构体,而 CFMB 是 FFAR2 和 FFAR3 特异性受体的激动剂,对 hFFAR2 的 EC50 值为 0.8 μM,对 rFFAR2 的 EC50 值为 0.2 μM。
(R)-Fasiglifam 是 Fasiglifam (MS-X09941) 的异构体,可作为实验中的对照化合物,而 Fasiglifam (TAK-875) 是一种有效的、可口服的、具有选择性的 GPR40 激动剂,EC50 值为 72 nM。
(rel)-AM-6226 是 AM-6226 (MS-X59177) 的相对立体异构体,而 AM-6226 是一种强效且具有口服活性的 G 蛋白偶联受体 40 (GPR40) 完全激动剂(EC50 值为 0.12 μM),能够激活胰腺 β 细胞和肠内分泌 L 细胞上的 GPR40 受体,以葡萄糖依赖的方式促进胰岛素分泌,还能增加肠促胰岛素激素 (GLP-1, GIP) 的释放,从而避免低血糖风险,可用于糖尿病等代谢性疾病的研究。
(S)-GLPG0974 是 GLPG0974 (MS-V57167) 的异构体,可作为实验中的对照化合物,而 GLPG0974 是游离脂肪酸受体-2 (free fatty acid receptor-2 (FFA2/GPR43)) 拮抗剂,IC50 值为 9 nM。
(±)-Pinocembrin((±)-5,7-Dihydroxyflavanone)是一种 GPR120 配体,可促进 HaCaT 细胞系的伤口愈合。
(±)-Pinocembrin (Standard) 是 (±)-Pinocembrin 的分析标准品,用于研究及分析应用,而 (±)-Pinocembrin ((±)-5,7-Dihydroxyflavanone) 是一种 GPR120 配体,能够促进 HaCaT 细胞系伤口愈合。
13Z,16Z-Docosadienoic acid 是一种具有杀菌活性的 GPR120 激动剂,可作为犬乳腺肿瘤的潜在生物标志物,并用于细菌感染、莱姆病、格雷夫斯病及乳腺肿瘤的研究。
3-Amino-3-(p-tolyl) propionic acid(3-Amino-3-(4-methylphenyl)propanoic acid)是一种 GPR40 激动剂,可用于 2 型糖尿病、肥胖症、代谢综合征及脂质紊乱的研究。
MOMBA 是一种通过结合 FFA2(Free Fatty Acid Receptor 2)正构位点激活受体信号通路的选择性正构激动剂,具有高度特异性,有望用于代谢性和炎症性疾病的研究。